X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (12) 12
aged (11) 11
female (11) 11
male (11) 11
middle aged (9) 9
oncology (9) 9
cancer (8) 8
clinical trials (8) 8
disease-free survival (8) 8
adult (7) 7
chemotherapy (7) 7
hematology, oncology and palliative medicine (6) 6
treatment outcome (6) 6
aged, 80 and over (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
colorectal cancer (5) 5
colorectal neoplasms - drug therapy (5) 5
colorectal neoplasms - pathology (5) 5
oxaliplatin (5) 5
prognosis (5) 5
tumors (5) 5
patients (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
camptothecin - administration & dosage (3) 3
camptothecin - analogs & derivatives (3) 3
cancer therapies (3) 3
care and treatment (3) 3
clinical study (3) 3
colorectal neoplasms - mortality (3) 3
drug therapy (3) 3
fluorouracil - administration & dosage (3) 3
leucovorin (3) 3
life sciences (3) 3
medical prognosis (3) 3
metastasis (3) 3
organoplatinum compounds - administration & dosage (3) 3
retrospective studies (3) 3
survival (3) 3
1st-line treatment (2) 2
adenocarcinoma (2) 2
adenocarcinoma - drug therapy (2) 2
adenocarcinoma - secondary (2) 2
analysis (2) 2
angiogenesis inhibitors (2) 2
antineoplastic agents - therapeutic use (2) 2
biomarkers (2) 2
carcinoma - pathology (2) 2
clinical outcomes (2) 2
combination (2) 2
deoxycytidine - administration & dosage (2) 2
deoxycytidine - analogs & derivatives (2) 2
double-blind method (2) 2
drug administration schedule (2) 2
efficacy (2) 2
epidemiology (2) 2
fluorouracil (2) 2
follow-up (2) 2
follow-up studies (2) 2
france (2) 2
irinotecan (2) 2
kaplan-meier estimate (2) 2
leucovorin - administration & dosage (2) 2
management (2) 2
medical colleges (2) 2
medical research (2) 2
medicine, experimental (2) 2
mutation (2) 2
neoplasm metastasis - drug therapy (2) 2
phenylurea compounds - therapeutic use (2) 2
plus irinotecan (2) 2
proportional hazards models (2) 2
proteins (2) 2
pyridines - therapeutic use (2) 2
risk factors (2) 2
studies (2) 2
surgery (2) 2
survival rate (2) 2
therapy (2) 2
time factors (2) 2
5-fluorouracil (1) 1
[ sdv ] life sciences [q-bio] (1) 1
[ sdv.mhep.heg ] life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (1) 1
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (1) 1
[sdv]life sciences [q-bio] (1) 1
abridged index medicus (1) 1
acquired-resistance (1) 1
acute coronary syndromes (1) 1
adenocarcinoma - blood (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - mortality (1) 1
adenoneuroendocrine carcinoma (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibody (1) 1
antineoplastic agents, hormonal - adverse effects (1) 1
antineoplastic agents, hormonal - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 937 - 948
Summary Background Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the... 
Hematology, Oncology and Palliative Medicine | KRAS MUTATIONS | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | RANDOMIZED PHASE-III | INHIBITS GROWTH | ACQUIRED-RESISTANCE | FLUOROURACIL | PLACEBO PLUS | TUMOR-GROWTH | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Clinical Trials, Phase III as Topic | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Precision Medicine | Receptor, TIE-1 - blood | Phosphatidylinositol 3-Kinases - blood | Genetic Predisposition to Disease | Adenocarcinoma - blood | ras Proteins - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Phenotype | Class I Phosphatidylinositol 3-Kinases | Biomarkers, Tumor - genetics | ras Proteins - genetics | Patient Selection | DNA, Neoplasm - blood | Female | Adenocarcinoma - genetics | Retrospective Studies | Pyridines - therapeutic use | Colorectal Neoplasms - mortality | Colorectal Neoplasms - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Phenylurea Compounds - therapeutic use | Proto-Oncogene Proteins B-raf - blood | Proto-Oncogene Proteins - genetics | Treatment Outcome | Randomized Controlled Trials as Topic | Biomarkers, Tumor - blood | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | Aged | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins - blood | Adenocarcinoma - mortality | Medical colleges | Medical research | Cancer patients | Prognosis | Liver | DNA | Colorectal cancer | Genetic research | Medicine, Experimental | Metastasis | Life Sciences | Human health and pathology
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 1, pp. 29 - 37
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 510 - 519
Summary Background Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its... 
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 305 - 314
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 632 - 641
Journal Article